ESSA Accounts Payable from 2010 to 2024
EPIX Stock | USD 1.60 0.01 0.62% |
Accounts Payable | First Reported 2013-09-30 | Previous Quarter 1.9 M | Current Value 2.4 M | Quarterly Volatility 742.8 K |
Check ESSA Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ESSA Pharma's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 8.2 M, as well as many indicators such as Price To Sales Ratio of 272.8 K, Dividend Yield of 0.0 or PTB Ratio of 49.54. ESSA financial statements analysis is a perfect complement when working with ESSA Pharma Valuation or Volatility modules.
ESSA | Accounts Payable |
Latest ESSA Pharma's Accounts Payable Growth Pattern
Below is the plot of the Accounts Payable of ESSA Pharma over the last few years. An accounting item on the balance sheet that represents ESSA Pharma obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of ESSA Pharma are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. ESSA Pharma's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ESSA Pharma's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable | 10 Years Trend |
|
Accounts Payable |
Timeline |
ESSA Accounts Payable Regression Statistics
Arithmetic Mean | 1,267,805 | |
Geometric Mean | 344,748 | |
Coefficient Of Variation | 78.14 | |
Mean Deviation | 793,761 | |
Median | 1,425,871 | |
Standard Deviation | 990,674 | |
Sample Variance | 981.4B | |
Range | 3.5M | |
R-Value | 0.45 | |
Mean Square Error | 841.8B | |
R-Squared | 0.20 | |
Significance | 0.09 | |
Slope | 99,951 | |
Total Sum of Squares | 13.7T |
ESSA Accounts Payable History
About ESSA Pharma Financial Statements
ESSA Pharma investors use historical fundamental indicators, such as ESSA Pharma's Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in ESSA Pharma. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Accounts Payable | 2.4 M | 1.5 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for ESSA Stock Analysis
When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.